HyperCORE International Clinical Research Network: FOMAT Joins as Founding Partner
HyperCORE International clinical research network represents one of the most significant structural innovations in the history of clinical trial site operations. FOMAT is proud to announce its participation as a founding partner of this global alliance, joining seven other industry leading research organizations under a shared ownership model designed to eliminate inefficiencies and deliver better outcomes for sponsors, CROs, and patients.
What Is HyperCORE International
HyperCORE International is a super network of highly experienced and recognized clinical research site and network companies. The founding members collectively bring over 100 years of combined experience in the clinical trial space, having completed more than 6,000 studies and helped evaluate thousands of new drugs and treatments across more than 60,000 patients.
Each member operates as an independent company while integrating common functions to streamline business and clinical operations through harmonization and the sharing of best practices. The HyperCORE International clinical research network provides Phase I through Phase IV clinical trial services and operates as the second largest worldwide network of research sites, with over 80 locations across five countries on two continents.
The network was built to address a longstanding structural problem in the industry. The highly fragmented and inefficient research site model has historically slowed study timelines and created inconsistencies in data quality. HyperCORE’s primary goal is to modernize this model by assembling the industry’s leading site networks under one collaborative structure and facilitating exponential efficiencies across the full study lifecycle.
“This is the realization of a vision several years in the making,” said Mark Lacy, CEO of Benchmark Research and CEO of HyperCORE. “I wanted to bring together a group of already highly successful and professionalized research site businesses in a new and powerful way. The magic lies within the mutual ownership model. Together, we can push the boundaries and lead the drive for further innovation. By banding together in such an intimate and integrated way, we can accelerate the entire end to end process from feasibility to close out. It’s research accelerated.”
The 8 Founding Partner Members
The HyperCORE International clinical research network launched with eight founding partner organizations, each a recognized leader in their respective markets:
Benchmark Research of Austin, Texas; Clinical Trials of Texas of San Antonio, Texas; DIEX Research of Montreal, Canada; FOMAT of Oxnard, California; IACT Health of Columbus, Georgia; LMC Manna Research of Toronto, Canada; Research Centers of America of Hollywood, Florida; and Wake Research of Raleigh, North Carolina.
The mutual ownership model that binds these organizations is central to what differentiates HyperCORE from a traditional CRO or site management organization. Each member has a direct stake in the collective performance of the network, creating alignment of incentives that motivates genuine collaboration.
Why FOMAT Joined HyperCORE
For FOMAT, joining the HyperCORE International clinical research network was a natural extension of its mission to diversify and innovate clinical research access. The partnership expands FOMAT’s capacity to support sponsors and CROs with faster startup times, harmonized operations, and access to larger and more diverse patient populations across multiple continents.
“We are excited to be part of this research site network,” said Nicholas Focil, CEO of FOMAT. “I strongly believe that we can change the existing business model through this innovative collaboration that creates a more efficient approach for our sponsors and patients.”
FOMAT brings to the HyperCORE International clinical research network over 10 years of experience in Phase II through Phase IV clinical trials across a wide range of therapeutic areas. Its investigator network and community based approach to patient recruitment complement the broader capabilities of the HyperCORE alliance, strengthening the network’s reach into underserved and diverse patient populations across the Americas.
To learn more about FOMAT’s capabilities or explore our active studies, visit fomatmedical.com. To learn more about HyperCORE International, visit hypercore-international.com.